Literature DB >> 20172772

Update on primary sclerosing cholangitis.

Tom H Karlsen1, Erik Schrumpf, Kirsten M Boberg.   

Abstract

Early studies in primary sclerosing cholangitis (PSC) were concerned with disease characterization, and were followed by epidemiological studies of PSC and clinical subsets of PSC as well as a large number of treatment trials. Recently, the molecular pathogenesis and the practical handling of the patients have received increasing attention. In the present review we aim to give an update on the pathogenesis of PSC and cholangiocarcinoma in PSC, as well as to discuss the current opinion on diagnosis and treatment of PSC in light of the recent European Association for the Study of the Liver and the American Association for the Study of Liver Diseases practice guidelines. Copyright 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20172772     DOI： 10.1016/j.dld.2010.01.011

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN： 1590-8658            Impact factor:   4.088


  33 in total

1.  Sclerosing cholangitis in baboons (Papio spp) resembling primary sclerosing cholangitis of humans.

Authors:  A M Arenas-Gamboa; J J Bearss; G B Hubbard; B F Porter; M A Owston; E J Dick
Journal:  Vet Pathol       Date:  2011-09-20       Impact factor: 2.221

Review 2.  Genetics in PSC: what do the "risk genes" teach us?

Authors:  Trine Folseraas; Evaggelia Liaskou; Carl A Anderson; Tom H Karlsen
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 3.  Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.

Authors:  Mario Strazzabosco; Romina Fiorotto; Massimiliano Cadamuro; Carlo Spirli; Valeria Mariotti; Eleanna Kaffe; Roberto Scirpo; Luca Fabris
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-25       Impact factor: 5.187

4.  HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

Authors:  E K K Henriksen; M K Viken; M Wittig; K Holm; T Folseraas; S Mucha; E Melum; J R Hov; K N Lazaridis; B D Juran; O Chazouillères; M Färkkilä; D N Gotthardt; P Invernizzi; M Carbone; G M Hirschfield; S M Rushbrook; E Goode; C Y Ponsioen; R K Weersma; B Eksteen; K K Yimam; S C Gordon; D Goldberg; L Yu; C L Bowlus; A Franke; B A Lie; T H Karlsen
Journal:  HLA       Date:  2017-07-11       Impact factor: 4.513

5.  Recurrence of primary sclerosing cholangitis after liver transplantation - The Hungarian experience.

Authors:  Fanni Gelley; Gergely Zádori; Dénes Görög; László Kóbori; Imre Fehérvári; György Gámán; Zsuzsanna Gerlei; Péter Nagy; Enikő Sárváry; Balázs Nemes
Journal:  Interv Med Appl Sci       Date:  2014-03-14

Review 6.  The genetics of complex cholestatic disorders.

Authors:  Gideon M Hirschfield; Roger W Chapman; Tom H Karlsen; Frank Lammert; Konstantinos N Lazaridis; Andrew L Mason
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

7.  Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.

Authors:  Johannes R Hov; Verena Keitel; Jon K Laerdahl; Lina Spomer; Eva Ellinghaus; Abdou ElSharawy; Espen Melum; Kirsten M Boberg; Thomas Manke; Tobias Balschun; Christoph Schramm; Annika Bergquist; Tobias Weismüller; Daniel Gotthardt; Christian Rust; Liesbet Henckaerts; Clive M Onnie; Rinse K Weersma; Martina Sterneck; Andreas Teufel; Heiko Runz; Adolf Stiehl; Cyriel Y Ponsioen; Cisca Wijmenga; Morten H Vatn; Pieter C F Stokkers; Severine Vermeire; Christopher G Mathew; Benedicte A Lie; Ulrich Beuers; Michael P Manns; Stefan Schreiber; Erik Schrumpf; Dieter Häussinger; Andre Franke; Tom H Karlsen
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

Review 8.  Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies.

Authors:  James H Tabibian; Steven P O'Hara; Keith D Lindor
Journal:  Scand J Gastroenterol       Date:  2014-07-03       Impact factor: 2.423

Review 9.  Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Marion J Pollheimer; Peter Fickert
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

10.  Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.

Authors:  Dana Tedesco; Manoj Thapa; Chui Yoke Chin; Yong Ge; Minghao Gong; Jing Li; Sanjeev Gumber; Patrick Speck; Elizabeth J Elrod; Eileen M Burd; William H Kitchens; Joseph F Magliocca; Andrew B Adams; David S Weiss; Mansour Mohamadzadeh; Arash Grakoui
Journal:  Gastroenterology       Date:  2018-02-15       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.